CRISPR Therapeutics AG revenue breakdown overview

CRISPR Therapeutics AG revenue for the last year amounted to 371.21 M USD, the most of which — 370.00 M USD — came from its highest performing source at the moment, Collaboration, the year earlier bringing 436.00 k USD. The greatest contribution to the revenue figure was made by Switzerland and United States — last year it brought CRISPR Therapeutics AG 371.21 M USD, and the year before that — 1.20 M USD.